Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Clinical Therapeutics
|
October 13, 2012
Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study
Robert A Riesenberg, Irina Baldytcheva, Catherine Datto
Open Access Rheumatology : Research and Reviews
|
February 26, 2013
Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses
Catherine Datto, Richard Hellmund, Mohd Kashif Siddiqui
The American Journal of Gastroenterology
|
June 13, 2012
Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009
Loren Laine, Huiying Yang, Shih-Chen Chang, et al.
Journal of Affective Disorders
|
May 4, 2013
Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder
Julie C Locklear, Henrik Svedsäter, Catherine Datto, et al.
Pain Medicine (Malden, Mass.)
|
February 9, 2018
The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain
Anita Gupta, Karin S Coyne, Catherine Datto, et al.
International Clinical Psychopharmacology
|
August 4, 2012
Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate
David V Sheehan, Julie Locklear, Henrik Svedsäter, et al.
Clinical Therapeutics
|
April 28, 2009
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects
Catherine Datto, Lovisa Berggren, Jitendra B Patel, et al.
Journal of Thrombosis and Thrombolysis
|
December 26, 2013
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Dominick J Angiolillo, Catherine Datto, Shane Raines, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 30, 2018
Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy
Perry G Fine, Yen-Wen Chen, Eric Wittbrodt, et al.
International Journal of Geriatric Psychiatry
|
October 17, 2012
Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder
Irina Mezhebovsky, Kairi Mägi, Fahua She, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Clinical Therapeutics
|
October 13, 2012
Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study
Robert A Riesenberg, Irina Baldytcheva, Catherine Datto
Open Access Rheumatology : Research and Reviews
|
February 26, 2013
Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses
Catherine Datto, Richard Hellmund, Mohd Kashif Siddiqui
The American Journal of Gastroenterology
|
June 13, 2012
Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009
Loren Laine, Huiying Yang, Shih-Chen Chang, et al.
Journal of Affective Disorders
|
May 4, 2013
Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder
Julie C Locklear, Henrik Svedsäter, Catherine Datto, et al.
Pain Medicine (Malden, Mass.)
|
February 9, 2018
The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain
Anita Gupta, Karin S Coyne, Catherine Datto, et al.
International Clinical Psychopharmacology
|
August 4, 2012
Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate
David V Sheehan, Julie Locklear, Henrik Svedsäter, et al.
Clinical Therapeutics
|
April 28, 2009
Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects
Catherine Datto, Lovisa Berggren, Jitendra B Patel, et al.
Journal of Thrombosis and Thrombolysis
|
December 26, 2013
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies
Dominick J Angiolillo, Catherine Datto, Shane Raines, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 30, 2018
Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy
Perry G Fine, Yen-Wen Chen, Eric Wittbrodt, et al.
International Journal of Geriatric Psychiatry
|
October 17, 2012
Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder
Irina Mezhebovsky, Kairi Mägi, Fahua She, et al.
Page
of 4